Development of a condensed locus control region cassette and testing in retrovirus vectors for (A)γ-globin

Blood Cells, Molecules, and Diseases

Volumn 24, Issue 3, 1998, Pages 322-339

  Emery, David W ^a   Chen, Hsiaoli ^b   Li, Qiliang ^b   Stamatoyannopoulos, George ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b University of Washington ^*

Author keywords

Cell line; Expression; Gene regulation; Gene therapy; Globin; Hematopoietic; Locus control region; Retrovirus

Indexed keywords

ALPHA GLOBIN; BETA GLOBIN; DNA; GAMMA GLOBIN; MESSENGER RNA; VIRUS VECTOR;

ADULT; ANIMAL CELL; ARTICLE; COLONY FORMATION; ENHANCER REGION; FETUS; GENE; GENE CASSETTE; GENE CONTROL; GENE EXPRESSION; GENETIC STABILITY; HUMAN; HUMAN CELL; MOUSE; MURINE LEUKEMIA VIRUS; NONHUMAN; PLASMID; PRIORITY JOURNAL; RETROVIRUS;

ANIMALIA; DNA VIRUSES; MURINAE; MURINE LEUKEMIA VIRUS; UNIDENTIFIED RETROVIRUS;

EID: 0032170660     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1006/bcmd.1998.0200     Document Type: Article

References (67)

1. 1. Weatherall DJ. The Thalassemias. In: Stamatoyannopoulos G, Nienhuis AW, Majerus PW, Varmus H, eds. Molecular Basis of Blood Diseases. Philadelphia, PA: WB Saunders Company, pp. 157-206, 1993.
2. 2. Charache S, Terrin ML, Moore RD. Multicenter study of hydroxyurea: Effects of hydroxyurea on the frequency of painful crises in sickle cell anemia. N Engl J Med 332: 1317-1322, 1995.
3. 3. Walters MC, Patience M, Leisenring W, et al. Bone marrow transplantation for sickle cell disease. N Engl J Med 335: 369-376, 1996.
4. 4. Lucarelli G, Galimberti M, Polchi P, et al. Marrow transplantation in patients with thalassemia responsive to iron chelation therapy. N Engl J Med 329: 840-844, 1993.
5. 5. Cone RD, Weber-Benarous A, Baorto D, Mulligan RC. Regulated expression of a complete human β-globin gene encoded by a transmissible retrovirus vector. Mol Cell Biol 7: 887-897, 1987.
6. 6. Dzierzak EA, Papayannopoulou T, Mulligan RC. Lineage-specific expression of a human β-globin gene in murine bone marrow transplant recipients reconstituted with retrovirus-transduced stem cells. Nature 331: 35-41, 1988.
7. 7. Karlsson S, Bodine DM, Perry L, Papayannopoulou T, Nienhuis AW. Expression of the human β globin gene following retroviral-mediated transfer into multipotential hematopoietic progenitors of mice. Proc Natl Acad Sci USA 85: 6062-6066, 1988.
8. 8. Miller AD, Bender MA, Harris EAS, Kaleko M, Gelinas RE. Design of retrovirus vectors for transfer and expression of the human β globin gene. J Virol 62: 4337-4345, 1988.
9. 9. Bender MA, Gelinas RE, Miller AD. A majority of mice show long-term expression of a human β-globin gene after retrovirus transfer into hematopoietic stem cells. Mol Cell Biol 9: 1426-1434, 1989.
10. 10. Leboulch P, Huang GMS, Humphries RK, et al. Mutagenesis of retroviral vectors transducing human β-globin gene and β-globin locus control region derivatives results in stable transmission of an active transcription structure. EMBO J 13: 3065-3076, 1994.
11. 11. Bodine DM, Karlsson S, Nienhuis AW. Combination of interleukin 3 and 6 preserves stem cell function in culture and enhances retrovirus-mediated gene transfer into hematopoietic stem cells. Proc Natl Acad Sci USA 86: 8897-8901, 1989.
12. 12. Sadelain M, Wang CHJ, Antoniou M, Grosveld F, Mulligan RC. Generation of a high-titer retroviral vector capable of expressing high levels of the human β-globin gene. Proc Natl Acad Sci USA 92: 6728-6732, 1995.
13. 13. Raftopoulos H, Ward M, Leboulch P, Bank A. Long-term transfer and expression of the human β-globin gene in a mouse transplant model. Blood 90: 3414-3422, 1997.
14. 14. Rixon MW, Harris EAS, Gelinas RE. Expression of the human γ-globin gene after retroviral transfer to transformed erythroid cells. Biochem 29: 4393-4400, 1990.
15. 15. Ren S, Wong BY, Li J, Luo X-N, Wong PMC, Atweh GF. Production of genetically stable high-titer retroviral vectors that carry a human γ-globin gene under the control of the α-globin locus control region. Blood 87: 2518-2524, 1996.
16. 16. Grosveld F, Blom van Assendelft G, Greaves DR, Kollias G. Position-independent, high-level expression of the human β-globin gene in transgenic mice. Cell 51: 975-985, 1987.
17. 17. Tuan D, Solomon W, Li Q, London IM. The "β-like globin" gene domain in human erythroid cells. Proc Natl Acad Sci USA 82: 6384-8388, 1985.
18. 18. Forrester WC, Thompson C, Elder JT, Grudine M. A developmentally stable chromatin structure in the human β-globin gene cluster. Proc Natl Acad Sci USA 83: 1359-1363, 1986.
19. 19. Forrester WC, Takegawa S, Papayannopoulos T, Stamatoyannopoulos G, Grudine M. Evidence for a locus activation region: the formation of developmentally stable hypersensitive sites in globin-expressing hybrids. Nucleic Acids Res 15: 10159-10177, 1987.
20. 20. Talbot D, Colliis P, Antoniou M, Vidal M, Grosveld F, Greaves DR. A dominant control region from the human β-globin locus conferring integration site-independent gene expression. Nature 338: 352-355, 1989.
21. 21. Stamatoyannopoulos G, Nienhuis AW. Hemoglobin switching. In: Stamatoyannopoulos G, Nienhuis AW, Majerus PW, Varmus H, eds. The Molecular Basis of Blood Diseases. Philadelphia, PA: WB Saunders Company, pp. 107-156, 1994.
22. 22. van Assendelft GB, Hanscombe O, Grosveld F, Greaves R. The β-globin dominant control region activates homologous and heterologous promoters in a tissue-specific manner. Cell 56: 969-977, 1989.
23. 23. Li Q, Zhou B, Powers P, Enver T, Stmatoyannopoulos G. β-globin lous ativation regions: conservation of organization, structure, and function. Proc Natl Acad Sci USA 87: 8207-8211, 1990.
24. 24. Shelton DA, Stegman L, Hardison R, et al. Phylogenetic footprining of hypersensitive site 3 of the β-globin locus control region. Blood 89: 3457-3469, 1997.
25. 25. Reitman M, Felsenfeld G. Mutational analysis of the chicken β-globin enhancer reveals two positive-acting domains. Proc Natl Acad Sci USA 85: 6267-6271, 1988.
26. 26. Orkan SH. GATA-binding transcription factors in hematopoietic cells. Blood 80: 575-581, 1992.
27. 27. Tuan DY, Solomon WB, London IM, Lee DP. An erythroid-specific, developmental-stage-independent enhancer far upstream of the human "β-like' genes. Proc Natl Acad Sci USA 86: 2554-2558, 1989.
28. 28. Fraser P, Pruzina S, Antoniou M, Gros veld F. Each hypersensitive site of the human β-globin lous control region confers a different developmental pattern of expression on the globin genes. Genes and Dev 7: 106-113, 1993.
29. 29. Navas PA, Peterson KR, Li Q, Skarpidi E, et al. Developmental specificity of the interaction between the locus control region and embryonic or fetal globin genes in transgenic mice with an HS3 core deletion. Mol Cel Biol 18:4188-96.
30. 30. Pasceri P, Pannell D, Wu X, Ellis J. Full activity from human β-globin locus control region transgenes requires 5'HS1, distal β-globin promoter and 3' β-globin sequences. Blood 92: 1-12, 1998.
31. 31. Miller AD, Rosman GJ. Improved retroviral vectors for gene transfer and expression. BioTechniques 7: 980-890, 1989.
32. 32. Forrester WC, Novak U, Gelinas R, Grudine M. Molecular analysis of the human β-globin locus activation region. Proc Natl Acad Sci USA 86: 5439-5443, 1989.
33. 33. Sorrentino BP, Brandt SJ, Bodine DM, et al. Selection of drug-resistant bone marrow cells in vivo after retroviral transfer of human MDR1. Science 257: 99-103, 1992.
34. 34. Allay JA, Spencer HT, Wilkinson SL, Belt JA, Blakley RL, Sorrentino BP. Sensitization of hemato-poietic stem and progenitor cells to trimetrexate using nucleoside transport inhibitors. Blood 90: 3546-3554, 1997.
35. 35. Jin L, Siritanaratkul N, Emery DW, et al. Targeted expansion of genetically modified bone marrow cells. Proc Natl Acad Sci USA 95: 8093-8097, 1998.
36. 36. Einerhand MPW, Antoniou M, Zolotukhin S, et al. Regulated high-level human β-globin gene expression in erythroid cells following recombinant adeno-associated virus-mediated gene transfer. Gene Therapy 2: 336-343, 1995.
37. 37. Hargrove PW, Vanin EF, Kurtzman GJ, Nienhuis AW. High-level globin gene expression mediated by a recombinant adeno-associated virus genome that contains the 3' γ globin gene regulatory element and integrates as tandem copies in erythroid cells. Blood 89: 2167-2175, 1997.
38. 38. Ulrich MJ, Ley TJ. Function of normal and mutated γ-globin gene promoters in electroporated K562 erythroleukemia cells. Blood 75: 990-999, 1990.
39. 39. Moon AM, Ley TJ. Functional properties of the β-globin locus control region in K562 erythroleukemia cells. Blood 77: 2272-2284, 1991.
40. 40. Sambrook J, Fritsch EF, Maniatis T, eds. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Press, 1989.
41. 41. Enver T, Brice M, Karlinsey J, Stamatoyannopoulos G, Papayannopoulou T. Developmental regulation of fetal to adult globin gene swithing in human fetal x mouse erytholeukemia cell hybrids. Develop Biol 148: 129-137, 1991.
42. 42. Lozzio CB, Lozzio BB. Human chronic myelogenous leukemia cell line with positive Philadelphia chromosome. Blood 45: 321-324, 1975.
43. 43. Miller AD, Buttimore C. Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol Cell Biol 6: 2895-902, 1986.
44. 44. Chen H, Yoshimura FK. Identification of a region of a murine leukemia virus long terminal repeat with novel transcriptional regulatory activities. J Virol 68: 3308-3316, 1994.
45. 45. McBurney MW, Sutherland LC, Adra CN, Leclair B, Rudnicki MA, Jardine K. The mouse Pgk-1 gene promoter contains an upstream activator sequence. Nucleic Acids Res 19: 5755-61, 1991.
46. 46. Bodine DM, McDonagh KT, Brandt SJ, et al. Development of a high-titer retrovirus producer cell line capable of gene transfer into rhesus monkey hematopoietic stem cells. Proc Natl Acad Sci USA 87: 3738-42, 1990.
47. 47. Li Q, Stamatoyannopoulos G. Position independence and proper developmental control of γ-globin gene expression requires both a 5' locus control region and downstream sequence element. Mol Cell Biol 14: 6087-6096, 1994.
48. 48. Thorpe SJ, Thein SL, Sampietro M, Craig JE, Mahon B, Huehns ER. Immunochemical estimation of haemoglobin types in red blood cells by FACS analysis. Brit J Haematol 87: 125-132, 1994.
49. 49. Talbot D, Philipsen S, Fraser P, Grosveld F. Detailed analysis of the site 3 region of the human β-globin dominant control region. EMBO J 9: 2169-2178, 1990.
50. 50. Philipsen S, Talbot D, Fraser P, Grosveld F. The β-globin dominant control region: hypersensitive site 2. EMBO J 9: 2159-2167, 1990.
51. 51. Prunzina S, Hancombe O, Whyatt D, Grosveld F, Philipsen S. Hypersensitive site 4 of the human β globin locuscontrol region. Nucleic Acid Res 19: 1413-1419, 1991.
52. 52. Mignotte V, Wall L, deBoer E, Grosveld F, Romeo PH. Two tissue-specific factors bind the erythroid promoter of the human porphobilinogen deaminase gene. Nucleic Acids Res 17: 37-54, 1989.
53. 53. Andrews NC, Erdjument-Bromage H, Davidson MB, Tempst P, Orkan SH. Erythroid transcription factor NF-E2 is a haematopoietic-specific basic-leuine zipper protein. Nature 362: 722-728, 1993.
54. 54. Rutherford TR, Glegg JB, Weatherall DJ. K562 human leukemic cells synthesise embryonic haemoglobin in response to hemin. Nature 280: 164-5, 1979.
55. 55. Stamatoyannopoulos G, Josephson B, Zhang J-W, Li Q. Developmental regulation of human γ-globin genes in transgenic mice. Mol Cel Biol 13: 7636-7644, 1993.
56. 56. Myers RM, Tulley K, Maniatis T. Fine structure genetic analysis of a β-globin promoter. Science 232: 613-618, 1986.
57. 57. Ellis J, Tan-Un KC, Harper A, Michalovich D. A dominant chromatin-opening activity in 5' hypersensitive site 3 of the human β-globin locus control region. EMBO J. 15, 562-568, 1996.
58. 58. Pathak VK, Temin HM. Broad spectrum of in vivo forward mutations, hypermutations, and mutational hotspots in a retroviral shuttle vector after a single replication cycle: substitutions, frameshifts, and hypermutations. Proc Natl Acad Sci USA 87: 6019-6023, 1990.
59. Aγ-globin gene. Mol Cel Biol 17: 240-247, 1997.
60. 60. Morley BJ, Abbott CA, Wood WG. Regulation of human fetal and adult globin genes in mouse erythroleukemia cells. Blood 78: 1355-1363, 1991.
61. Aγ globin gene promoter mutants in MEL cells and in transgenic mice. In press.
62. 62. Platt OS, Brambilla DJ, Rosse WF, et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med 330: 1639-44, 1994.
63. 63. Delviks KA, Hu W-S, Pathak VK. ψ-vectors: murine leukemia virus-based self-inactivating and self-activating retroviral vectors. J Virol 71: 6218-6224, 1997.
64. 64. LeGuern C, Shimada H, Emery DW, Germana S, Shafer GE, Sach DH. Retrovirus-mediated transfer of MHC class II cDNA into swine bone marrow cells. J Mol Med 73: 269-278, 1995.
65. 65. Goodrich DW, Duesberg PH. Retroviral recombination during reverse transcription. Proc Natl Acad Sci USA 87: 2052-2056, 1990.
66. 66. Wahlfors JJ, Xanthopoulos KG, Morgan RA. Semliki forest virus-mediated production of retroviral vector RNA in retroviral packaging cells. Hum Gene Therapy 8: 2031-2041, 1997.
67. 67. Wijgerde M, Grosveld F, Fraser P. Transcription complex stability and chromatin dynamics in vivo. Nature 377: 209-213, 1995.